Literature DB >> 25044256

High early cardiovascular mortality after liver transplantation.

Lisa B VanWagner1, Brittany Lapin, Josh Levitsky, John T Wilkins, Michael M Abecassis, Anton I Skaro, Donald M Lloyd-Jones.   

Abstract

Cardiovascular disease (CVD) contributes to excessive long-term mortality after liver transplantation (LT); however, little is known about early postoperative CVD mortality in the current era. In addition, there is no model for predicting early postoperative CVD mortality across centers. We analyzed adult recipients of primary LT in the Organ Procurement and Transplantation Network (OPTN) database between February 2002 and December 2012 to assess the prevalence and predictors of early (30-day) CVD mortality, which was defined as death from arrhythmia, heart failure, myocardial infarction, cardiac arrest, thromboembolism, and/or stroke. We performed logistic regression with stepwise selection to develop a predictive model of early CVD mortality. Sex and center volume were forced into the final model, which was validated with bootstrapping techniques. Among 54,697 LT recipients, there were 1576 deaths (2.9%) within 30 days. CVD death was the leading cause of 30-day mortality (40.2%), and it was followed by infection (27.9%) and graft failure (12.2%). In a multivariate analysis, 9 significant covariates (6 recipient covariates, 2 donor covariates, and 1 operative covariate) were identified: age, preoperative hospitalization, intensive care unit status, ventilator status, calculated Model for End-Stage Liver Disease score, portal vein thrombosis, national organ sharing, donor body mass index, and cold ischemia time. The model showed moderate discrimination (C statistic = 0.66, 95% confidence interval = 0.63-0.68). In conclusion, we provide the first multicenter prognostic model for the prediction of early post-LT CVD death, the most common cause of early post-LT mortality in the current transplant era. However, evaluations of additional CVD-related variables not collected by the OPTN are needed in order to improve the model's accuracy and potential clinical utility.
© 2014 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2014        PMID: 25044256      PMCID: PMC4213202          DOI: 10.1002/lt.23950

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  45 in total

1.  Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation.

Authors:  Celina M Yong; Madan Sharma; Victor Ochoa; Freddy Abnousi; John Roberts; Nathan M Bass; Claus U Niemann; Stephen Shiboski; Megha Prasad; Mehdi Tavakol; Thomas A Ports; Gabriel Gregoratos; Yerem Yeghiazarians; Andrew J Boyle
Journal:  Liver Transpl       Date:  2010-11       Impact factor: 5.799

Review 2.  Public reporting of 30-day mortality for patients hospitalized with acute myocardial infarction and heart failure.

Authors:  Harlan M Krumholz; Sharon-Lise T Normand
Journal:  Circulation       Date:  2008-08-25       Impact factor: 29.690

Review 3.  The coagulopathy of chronic liver disease.

Authors:  Armando Tripodi; Pier Mannuccio Mannucci
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

Review 4.  Pre operative cardio pulmonary assessment of the liver transplant candidate.

Authors:  Graciela Martinez-Palli; Andrés Cárdenas
Journal:  Ann Hepatol       Date:  2011 Oct-Dec       Impact factor: 2.400

5.  [Causes of early mortality after liver transplantation: a twenty-years single centre experience].

Authors:  B Jung; M Cisse; G Chanques; E Arsac; M Bismuth; F Panaro; P-F Perrigault; B Souche; B Gallix; D Verzilli; J-M Delay; F Navarro; G-P Pageaux; S Jaber
Journal:  Ann Fr Anesth Reanim       Date:  2011-10-27

Review 6.  Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation.

Authors:  S M Strasberg; T K Howard; E P Molmenti; M Hertl
Journal:  Hepatology       Date:  1994-10       Impact factor: 17.425

7.  Safety of outpatient laparoscopic cholecystectomy in the elderly: analysis of 15,248 patients using the NSQIP database.

Authors:  Ajit Rao; Antonio Polanco; Sujing Qiu; Joseph Kim; Edward H Chin; Celia M Divino; Scott Q Nguyen
Journal:  J Am Coll Surg       Date:  2013-09-14       Impact factor: 6.113

8.  Cardiovascular complications following liver transplantation.

Authors:  G W Dec; N Kondo; M L Farrell; J Dienstag; A B Cosimi; M J Semigran
Journal:  Clin Transplant       Date:  1995-12       Impact factor: 2.863

9.  An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.

Authors:  Armando Tripodi; Massimo Primignani; Veena Chantarangkul; Alessandra Dell'Era; Marigrazia Clerici; Roberto de Franchis; Massimo Colombo; Pier Mannuccio Mannucci
Journal:  Gastroenterology       Date:  2009-08-23       Impact factor: 22.682

10.  Liver transplantation in recipients over 65 yr old: a single center experience.

Authors:  M Audet; T Piardi; F Panaro; M Cag; E Ghislotti; H Habibeh; S M Giulini; D Jaeck; P h Wolf
Journal:  Clin Transplant       Date:  2009-02-17       Impact factor: 2.863

View more
  50 in total

1.  A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: The CAR-OLT score.

Authors:  Lisa B VanWagner; Hongyan Ning; Maureen Whitsett; Josh Levitsky; Sarah Uttal; John T Wilkins; Michael M Abecassis; Daniela P Ladner; Anton I Skaro; Donald M Lloyd-Jones
Journal:  Hepatology       Date:  2017-11-06       Impact factor: 17.425

Review 2.  PRO: Cardiac Catheterization Is the Optimal Strategy for Cardiovascular Risk Stratification in This Patient.

Authors:  Brett Sadowski; Tilak Baba; Amol S Rangnekar
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

Review 3.  CON: Noninvasive Imaging Is the Preferred Strategy for Cardiovascular Risk Stratification in This Patient.

Authors:  Shravan Dave; Abbey Barnard; Michel Mendler
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

4.  Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.

Authors:  Lisa B VanWagner; Brittany Lapin; Anton I Skaro; Donald M Lloyd-Jones; Mary E Rinella
Journal:  Liver Int       Date:  2015-06-03       Impact factor: 5.828

5.  Mind the Gap: Statin Underutilization and Impact on Mortality in Liver Transplant Recipients.

Authors:  Patrick T Campbell; Lisa B VanWagner
Journal:  Liver Transpl       Date:  2019-10       Impact factor: 5.799

6.  The relationship between coronary artery disease and cardiovascular events early after liver transplantation.

Authors:  Samarth S Patel; Fei-Pi Lin; Viviana A Rodriguez; Chandra Bhati; Binu V John; Taylor Pence; Mohammad B Siddiqui; Adam P Sima; Antonio Abbate; Trevor Reichman; Mohammad S Siddiqui
Journal:  Liver Int       Date:  2019-03-26       Impact factor: 5.828

7.  A simple clinical calculator for assessing cardiac event risk in liver transplant candidates: The cardiovascular risk in orthotopic liver transplantation score.

Authors:  Lisa B VanWagner
Journal:  Clin Liver Dis (Hoboken)       Date:  2018-07-26

Review 8.  Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.

Authors:  Benedict J Maliakkal
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

Review 9.  Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes After Liver Transplantation: A Systematic Review.

Authors:  Monica A Konerman; Danielle Fritze; Richard L Weinberg; Christopher J Sonnenday; Pratima Sharma
Journal:  Transplantation       Date:  2017-07       Impact factor: 4.939

10.  Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment After Liver Transplantation.

Authors:  Lisa B VanWagner; Samantha Montag; Lihui Zhao; Norrina B Allen; Donald M Lloyd-Jones; Arighno Das; Anton I Skaro; Samuel Hohmann; John J Friedewald; Josh Levitsky
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.